Condition: Neurodegenerative Diseases · Dementia · Sponsor: Monash University
This cohort study aims to determine if a blood test can aid with diagnosing dementia in anyone presenting with cognitive complaints to a single healthcare network. The investigators will measure levels of a brain protein, Neurofilament light chain (Nfl), and assess changes in language using speech tests. Participants will have a single blood test and speech test, and will be followed up at 12-months to complete questionnaires and cognitive scales over the phone. The speech test will also be completed again at 12-months. Individuals at risk of a Fronto-temporal dementia syndrome will be eligible to complete optional genetic testing involving an 'at home' saliva sample.
This description comes directly from the study's public registry record.
Prof. Amy Brodtmann, MBBS, FRACP, PhD, FANZAN · 03 9094 9540 · amy.brodtmann@monash.edu
Svetlana Ivanic, BSc(Hons) · svetlana.ivanic@monash.edu
Always discuss trial participation with your own doctor first.
| Box Hill Hospital | Box Hill, Victoria, Australia | Recruiting |
| Wantirna Health | Wantirna, Victoria, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06339190